DeepMed Research

IRCCS Azienda Ospedaliero-Universitaria di Bologna

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

5-methyltetrahydrofolate Survival and Inflammation in ESRD Patients

Not Applicable

Completed

Conditions: Mortality
Hyperhomocysteinemia
Inflammation

Interventions: Drug: 5-MTHF (5-methyltetrahydrofolate)
Drug: folic acid

First Posted Date: 2008-02-29

Last Posted Date: 2021-03-18

Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Target Recruit Count: 341

Registration Number: NCT00626223

Locations: 🇮🇹
Nephrology Dialysis and Renal Transplantation Unit, S.Orsola University Hospital, Bologna, Italy

Prospective Randomized Trial Comparing Lichtenstein's Repair of Inguinal Hernia With Polypropylene Mesh Versus Surgisis

Phase 4

Completed

Conditions: Hernia, Inguinal

Interventions: Device: Prolene Polypropylene Mesh
Device: Surgisis Inguinal Hernia Matrix

First Posted Date: 2008-02-13

Last Posted Date: 2021-03-18

Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Target Recruit Count: 70

Registration Number: NCT00614419

Locations: 🇮🇹
St.Orsola-Malpighi University Hospital, Bologna, Italy

Non-Invasive Mechanical Ventilation in Elderly Patients

Phase 4

Terminated

Conditions: Acute Respiratory Failure

Interventions: Device: Non-invasive mechanical ventilation using a BiPAP Vision or any other ICU ventilators with NIV option
Drug: standard medical therapy that includes salbutamol, prednisolone and antibiotics as needed
Drug: standard medical therapy plus oxygen that includes salbutamol, prednisolone and antibiotics as needed

First Posted Date: 2008-01-25

Last Posted Date: 2012-07-17

Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Target Recruit Count: 82

Registration Number: NCT00600639

Locations: 🇮🇹
Istituto Scientifico di Pavia Fondazione Salvatore Maugeri, Pavia, Italy

Continuous Infusion of Fentanyl in Preterm on MV

Phase 3

Completed

Conditions: Pain
Infant, Premature, Diseases
Respiration; Insufficient or Poor, Newborn

Interventions: Drug: 5% glucose solution
Drug: Fentanyl

First Posted Date: 2007-12-12

Last Posted Date: 2011-10-12

Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Target Recruit Count: 128

Registration Number: NCT00571636

Locations: 🇮🇹
St'Orsola-Malpighi General Hospital, Bologna, BO, Italy

Non-invasive Ventilation in Terminally Ill Cancer Patients

Phase 4

Completed

Conditions: Cancer

Interventions: Other: non invasive ventilation (NIV)

First Posted Date: 2007-09-21

Last Posted Date: 2012-07-17

Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Target Recruit Count: 200

Registration Number: NCT00533143

Locations: 🇮🇹
San'Orsola Malpighi Hospital, Bologna ITALY, Bologna, Italy

Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-controlled Trial

Phase 2

Completed

Conditions: Helicobacter Pylori Infection

First Posted Date: 2006-11-23

Last Posted Date: 2021-03-18

Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Target Recruit Count: 300

Registration Number: NCT00403364

Locations: 🇮🇹
S.Orsola/Malpighi Teaching Hospital, University, Bologna, Italy

Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis

Phase 3

Completed

Conditions: Thrombophlebitis

Interventions: Drug: LMWH parnaparin subcutaneously

First Posted Date: 2006-08-15

Last Posted Date: 2021-03-19

Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Target Recruit Count: 664

Registration Number: NCT00362947

Locations: 🇮🇹
Dept. Angiology & Blood Coagulation; University Hospital S.Orsola-Malpighi, Bologna, BO, Italy
🇮🇹
U.O. Medicina Critica, Piacenza, PC, Italy

D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence

Completed

Conditions: Pulmonary Embolism
Deep Vein Thrombosis

First Posted Date: 2005-12-15

Last Posted Date: 2021-03-19

Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Target Recruit Count: 355

Registration Number: NCT00266045

Locations: 🇮🇹
Dept. Angiology & Blood Coagulation; Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, BO, Italy

D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism

Phase 4

Completed

Conditions: Deep Vein Thrombosis
Pulmonary Embolism

First Posted Date: 2005-12-12

Last Posted Date: 2021-03-19

Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Target Recruit Count: 600

Registration Number: NCT00264277

Locations: 🇮🇹
Dept. of Angiology & Blood Coagulation, University Hospital S. Orsola-Malpighi, Bologna, BO, Italy

Helicobacter Pylori Eradication With a New Sequential Treatment

Phase 3

Completed

Conditions: Helicobacter Pylori Infection
Non Ulcer Dyspepsia
Gastric Ulcer
Gastritis
Duodenal Ulcer
Chronic Active Gastritis

First Posted Date: 2005-08-19

Last Posted Date: 2021-03-18

Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Target Recruit Count: 1000

Registration Number: NCT00132171

Locations: 🇮🇹
Gastroenterology - Nuovo Regina Margherita Hospital, Rome, Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy